Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead is a research paper published in Nature Reviews Endocrinology (2024). On theSindex it has a DataRank of 0.666. It has been cited 84 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.666
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Breakthrough T1D Canada (formerly JDRF Canada)
Grant: 1-SRA-2022-1229-S-B
Breakthrough T1D Canada (formerly JDRF Canada)
Grant: 5-CDA-2020-945-A-N
NIDDK NIH HHS
Grant: R01 DK133610
NIDDK NIH HHS
Grant: UC4 DK104218
NIDDK NIH HHS
Grant: R01 DK114233
NIDDK NIH HHS
Grant: R01 DK132104
NINDS NIH HHS
Grant: R01 NS122911
NIDDK NIH HHS
Grant: U24 DK104162
Breakthrough T1D Canada (formerly JDRF Canada)
Grant: 2-SRA-2021-1079-S-B
NIDDK NIH HHS
Grant: R01 DK120444
NIDDK NIH HHS
Grant: R01 DK128840
NIDDK NIH HHS
Grant: R01 DK133702
Breakthrough T1D Canada (formerly JDRF Canada)
Grant: 5-SRA-2020-1058-S-B
NIDDK NIH HHS
Grant: R01 DK132387
NIDDK NIH HHS
Grant: U01 DK104218
FWCI
35.65
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords